Skip to main content
ALK-Abelló logo

ALK-Abelló — Investor Relations & Filings

Ticker · ALK ISIN · DK0061802139 LEI · 529900SGCREUZCZ7P020 CO Manufacturing
Open in API
Filings indexed 1,210 across all filing types
Latest filing 2016-05-17 Board/Management Inform…
Country DK Denmark
Listing CO ALK

About ALK-Abelló

https://www.alk.net

ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.

Recent filings

Filing Released Lang Actions
Board/Management Information 2016
Board/Management Information Classification · 100% confidence The document explicitly announces that the Board of Directors has appointed Carsten Hellmann as the new President and CEO of the company (ALK). This content directly relates to changes in senior management personnel. Based on the provided definitions, this aligns perfectly with the 'Board/Management Information' category.
2016-05-17 English
ALK ansætter Carsten Hellmann som ny administrerende direktør
Board/Management Information Classification · 100% confidence The document is a corporate announcement (Selskabsmeddelelse) from ALK-Abelló A/S regarding the appointment of a new CEO, Carsten Hellmann. This falls under the category of management changes, which is explicitly defined as 'MANG' (Board/Management Information).
2016-05-17 English
ALK ansætter Carsten Hellmann som ny administrerende direktør
Board/Management Information Classification · 90% confidence The document is a press release announcing the appointment of Carsten Hellmann as the new Chief Executive Officer, representing a change in the company’s senior management. This fits the ’Board/Management Information’ category.
2016-05-17 Danish
Three-month interim report (Q1) 2016
Earnings Release Classification · 86% confidence The document is a press release providing unaudited Q1 financial results (revenues, EBITDA, free cash flow) and updated full-year guidance, which is characteristic of an Earnings Release. It is not a full interim report (no complete financial statements) nor a conference call transcript. Therefore, it fits the Earnings Release category. Q1 2016
2016-05-04 English
Three-month interim report (Q1) 2016
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive 'Three-month interim report (Q1) 2016' for ALK-Abelló A/S. It contains detailed financial statements (Income Statement, Balance Sheet, Cash Flow), business reviews, revenue breakdowns by geography and product line, and updated financial guidance. It is clearly a substantive financial report for a period shorter than a full fiscal year, not merely an announcement or a certification. Q1 2016
2016-05-04 English
Three-month interim report (Q1) 2016
Earnings Release Classification · 90% confidence The document is a press release summarizing first-quarter 2016 unaudited financial results (revenues, EBITDA, cash flow) and updated full-year guidance, with a notice of a conference call. It does not contain the full interim report or detailed financial statements and clearly serves as the initial announcement of quarterly results. This matches the definition of an Earnings Release (ER). Q1 2016
2016-05-04 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.